v3.26.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Information

The following table is a summary of segment information for three months ended March 31, 2026 and 2025 (amounts in thousands):

 

   March 31, 2026   March 31, 2025 
   For the three months ended 
   March 31, 2026   March 31, 2025 
   As Restated      
Net revenues          
Diagnostic services  $-   $- 
Consumer products   1,169    1,431 
Consolidated net revenue   1,169    1,431 
Cost of revenue          
Diagnostic services   -    232 
Consumer products   874    673 
Consolidated cost of revenue   874    905 
Depreciation and amortization expense          
Diagnostic services   -    334 
Consumer products   623    807 
Total Depreciation and amortization expense   623    1,141 
Operating and other expenses          
Diagnostic services   -    168 
Consumer products   511    1,061 
Unallocated corporate   2,962    2,834 
Total  operating and other expenses   3,473    4,063 
Income (loss) from operations, before income taxes          
Diagnostic services   -    (734)
Consumer products   (839)   (1,110)
Unallocated corporate   (2,962)   (2,834)
Total loss from operations, before income taxes   (3,801)   (4,678)
Income tax expense   (1,374)    - 
Total loss from operations, after income taxes   (5,175)   (4,678)
Net loss from continuing operations  $(5,175)  $(4,678)

 

The following table is a summary of segment information as of March 31, 2026 and December 31, 2025 (amounts in thousands):

 

   March 31, 2026   December 31, 2025 
   As Restated      
ASSETS          
Consumer products  $10,973   $11,614 
Unallocated corporate   47,494    48,257 
Total assets  $58,467   $59,871